Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK DDI Study of Etrumadenant and Itraconazole in Healthy Adults
NCT05154136Phase 1Completed
- Sponsor
- Arcus Biosciences
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of etrumadenant in solid tumor, sponsored by Arcus Biosciences. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-time Curve From 0 to Last Observed Non-zero Concentration and 1 more. Started Oct 2021; status: completed.
02
Drugs
etrumadenant
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05154136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154136.